Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia

被引:1
|
作者
Bekdas, Mervan [1 ]
Saygi, Bilgi [1 ]
Kilinc, Yasemin Baranoglu [2 ]
Kilinc, Erkan [3 ]
机构
[1] Bolu Abant Izzet Baysal Univ, Fac Med, Dept Pediat, Bolu, Turkiye
[2] Bolu Izzet Baysal State Hosp, Dept Pediat, Bolu, Turkiye
[3] Abant Izzet Baysal Univ, Fac Med, Dept Physiol, Bolu, Turkiye
关键词
Community-acquired pneumonia; Children; Neurogenic inflammation; Neuropeptides; PEPTIDE; PROCALCITONIN; BIOMARKER; NEURONS;
D O I
10.1007/s00431-023-05417-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Neurogenic inflammation is involved in the development and progression of respiratory inflammatory diseases. However, its role in community-acquired pneumonia (CAP) remains unclear. We therefore aimed to investigate plasma levels of neurogenic inflammation-related neuropeptides, calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), and procalcitonin (PCT) in pediatric patients with CAP and to assess their diagnostic value in viral and bacterial/mixed pneumonia. A total of 124 pediatric patients with CAP (1 month-18 years old) and 56 healthy children of similar ages were prospectively enrolled. The patients were classified as viral (n = 99) and bacterial/mixed (n = 25) pneumonia. Plasma levels of the peptides were quantified by ELISA. ROC analysis was performed to evaluate possible diagnostic value of the peptides. While plasma levels of CGRP, VIP and PCT were significantly higher in patients with CAP than in the control group, respectively, NPY levels were significantly lower. Moreover, plasma levels of all neuropeptides and PCT were significantly higher in bacterial pneumonia patients compared to viral pneumonia patients. ROC analysis revealed that CGRP, SP and NPY had a diagnostic value in distinguishing viral and bacterial/mixed pneumonia.Conclusions: Our findings suggest that these neuropeptides may be implicated in pediatric CAP. CGRP, SP and NPY together may be a promising candidate in distinguishing viral and bacterial/mixed pneumonia, however, for this, further studies are needed.What is Known:center dot Neurogenic inflammation contributes to the development and progression of respiratory inflammatory diseases such as chronic obstructive pulmonary disease and bronchial asthma.What is New:center dot Plasma levels of neurogenic inflammation related neuropeptides calcitonin gene-related peptide, substance P, vasoactive intestinal peptide and neuropeptide Y are changed in pediatric community-acquired pneumonia. Calcitonin gene-related peptide, substance P and neuropeptide Y are promising candidates in distinguishing viral and bacterial/mixed pneumonia.
引用
收藏
页码:1619 / 1627
页数:9
相关论文
共 50 条
  • [31] Comparing viral, bacterial, and coinfections in community-acquired pneumonia, a retrospective cohort study
    Waldeck, Frederike
    Lemmel, Solveig
    Panning, Marcus
    Kaeding, Nadja
    Essig, Andreas
    Rohde, Gernot
    Pletz, Mathias W.
    Witzenrath, Martin
    Boutin, Sebastien
    Rupp, Jan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 154
  • [32] Clinical epidemiological characteristics of hospitalized pediatric viral community-acquired pneumonia in China
    Feng, Qianyu
    Wang, Jinjin
    Wang, Xinyu
    Tian, Jiao
    Zhang, Linlin
    Dilmurat, Dilara
    Liu, Mengjia
    Ai, Junhong
    Feng, Guoshuang
    Zeng, Yueping
    Wang, Ran
    Xie, Zhengde
    JOURNAL OF INFECTION, 2025, 90 (03)
  • [33] Elevated plasma visfatin concentrations in patients with community-acquired pneumonia
    Hu, Wei
    Liu, Chang-Wen
    Su, Jun
    Lu, Jun
    Zhu, Ying
    Liu, Bing-Wei
    PEPTIDES, 2013, 43 : 8 - 12
  • [34] Antimicrobial peptide plasma concentrations in patients with community-acquired pneumonia
    Jendeberg, Anna Lange
    Stralin, Kristoffer
    Hultgren, Olof
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (06) : 432 - 437
  • [35] Plasma levels of soluble Axl correlate with severity of community-acquired pneumonia
    Ko, Chung-Po
    Yu, Yung-Luen
    Hsiao, Pei-Ching
    Yang, Shun-Fa
    Yeh, Chao-Bin
    MOLECULAR MEDICINE REPORTS, 2014, 9 (04) : 1400 - 1404
  • [36] Neutrophil to lymphocyte ratio in pediatric patients with asthmatic exacerbation and community-acquired pneumonia
    Xu, Mei
    Zhou, Lingfang
    Zhang, Jie
    Luo, Sha
    Zhao, Yunfeng
    Xiong, Wei
    BMC PEDIATRICS, 2023, 23 (01)
  • [37] Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia
    Querol-Ribelles, JM
    Tenias, JM
    Grau, E
    Querol-Borras, JM
    Climent, JL
    Gomez, E
    Martinez, I
    CHEST, 2004, 126 (04) : 1087 - 1092
  • [38] Usefulness and prognostic value of biomarkers in patients with community-acquired pneumonia in the emergency department
    Julian-Jimenez, Agustin
    Gonzalez del Castillo, Juan
    Javier Candel, Francisco
    MEDICINA CLINICA, 2017, 148 (11): : 501 - 510
  • [39] A validation and potential modification of the pneumonia severity index in elderly patients with community-acquired pneumonia
    Naito, Tateaki
    Suda, Takafumi
    Yasuda, Kazumasa
    Yamada, Takashi
    Todate, Akihito
    Tsuchiya, Tomoyoshi
    Sato, Jun
    Chida, Kingo
    Nakamura, Hirotoshi
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (08) : 1212 - 1219
  • [40] Community-acquired bacterial pneumonia in adult HIV-infected patients
    Cilloniz, Catia
    Garcia-Vidal, Carolina
    Moreno, Asuncion
    Miro, Jose M.
    Torres, Antoni
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (07) : 579 - 588